- £88.05m
- £71.63m
- £19.96m
- 100
- 40
- 86
- 91
Annual income statement for Intercede, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 10.4 | 11 | 9.93 | 12.1 | 20 |
| Cost of Revenue | |||||
| Gross Profit | 10.3 | 10.7 | 9.73 | 11.7 | 19.4 |
| Other Operating Expenses | |||||
| Total Operating Expenses | 9.2 | 9.37 | 9.54 | 11.5 | 14.7 |
| Operating Profit | 1.15 | 1.59 | 0.39 | 0.571 | 5.26 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 0.574 | 1.1 | 0.323 | 0.626 | 5.59 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.01 | 1.53 | 0.723 | 1.31 | 6.02 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.01 | 1.53 | 0.723 | 1.31 | 6.02 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.01 | 1.53 | 0.723 | 1.31 | 6.02 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.02 | 0.028 | 0.012 | 0.022 | 0.096 |
| Dividends per Share |